Biotech

Two businessmen pushing giant puzzle pieces together as the sun sets behind them
Pharma

Chugai strikes $200M deal for IgAN asset in Asian countries

Founded to address "drug lag" in Asia, Renalys is selling itself to Chugai, enabling the Roche unit to advance sparsentan in several countries.
Eric Sagonowsky Oct 24, 2025 9:40am
VanNaarden
Favicon Fierce Biotech

Lilly oncology head weighs in on FDA cancer drug policies

Oct 21, 2025 11:53am
Blue race track

Merck grows more ambitious about 'workhorse' TROP2 ADC

Oct 20, 2025 4:00pm
BIO
Favicon Fierce Biotech

'Why We Vaccinate': BIO targets lawmakers for immunization push

Oct 20, 2025 1:50pm
Akeso

Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC

Oct 19, 2025 10:45am
NVS

Novartis' Pluvicto slows progression in earlier prostate cancer

Oct 19, 2025 10:30am